ABSTRACT Low activity of 5'-nucleotidase (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5) in T lymphoblasts may explain the marked sensitivity of this cell to deoxynucleotide accumulation when compared to B Iymphoblasts. The relevance of such observations with cultured cells to the normal immune system requires the demonstration of similar differences in the 5'-nucleotidase activity of normal human lymphocyte subpopulations. Sheep erythrocyte (E) rosette-forming cells from normal thymus, tonsi , and peripheral mononuclear cells have 5'-nucleotidase activities of 1.7, 11.3, and 21.2 nmol/hr per 106 cells. Non-E-rosette forming cells from the peripheral blood or tonsil have 5'-nucleotidase activity comparable to the higher levels found in the peripheral E-RFC. Increased levels of5'-nucleotidase activity may be a marker for post-thymic T Iymphocytes.
tidase activity may be a marker for post-thymic T Iymphocytes.
T lymphoblasts have 5'-nucleotidase activity similar to values demonstrated for E-RFC in thymus, whereas cultured B lymphoblasts have 5'-nucleotidase activity 15 times greater than that of T lymphoblasts. On the basis of these observations, the 5'-nucleotidase deficiency in congenital agammaglobulinemia has been reevaluated. In these patients the data indicate that peripheral E-rosette forming cells have the enzyme deficiency, demonstrating an abnormality of T lymphocytes in this disorder of immunoglobulin production. Lymphocyte 5'-nucleotidase (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5) may have an important role in the regulation of the human immune system. Decreased activity of this purine catabolic enzyme has been observed in patients with primary immunoglobulin deficiency (1) (2) (3) (4) . However, it remains unclear whether an etiological relationship exists between the immune dysfunction and this enzyme deficiency.
A marked difference in 5'-nucleotidase activity has been proposed as the molecular basis for the differential susceptibility of B and T lymphoblast lines to the toxicity related to deoxynucleoside accumulation (5) (6) (7) . T lymphoblasts are killed by deoxyadenosine or deoxyguanosine, rapidly accumulate dATP or dGTP, and have very low levels of 5'-nucleotidase (5) (6) (7) (8) (9) (10) .
Peripheral lymphocytes were obtained, separated into Erosette forming cells and non-E-rosette forming cells, and characterized by described methods (11) (12) (13) . Lymphoid organs were obtained from children with no known immune dysfunction, and cells were separated from these tissues within 1 hr of surgery by using described methods (14) . Thymus biopsies were performed during cardiac surgery and tonsils were obtained after their removal as a part of normal medical management. Monocytes were obtained by using the microexudate adhesion technique (15) The 5'-nucleotidase activity in non-E-rosette forming cells from peripheral blood and tonsil was higher than that of Erosette forming cells. The enzyme activity in non-E-rosette forming cells from tonsil exceeded the activity of peripheral blood non-E-rosetting cells. These tissues had 5'-nucleotidase activity similar to cultured B lymphoblasts (Table 1 ). In contast, peripheral monocytes and granulocytes had low values for 5'-nucleotidase.
To assess whether the AMP dephosphorylating activity measured by our enzyme assay on the lymphocyte surface is specific for 5'-nucleotidase or is a nonspecific phosphatase, inhibition of dephosphorylating activity by 25 (1) (2) (3) (4) . Because abnormal T lymphocyte subpopulations may underlie the pathogenesis of the immune deficiency in these diseases (17, 18) , we compared the 5'-nucleotidase activity in peripheral E-rosette forming lymphocytes from nine normal subjects and five patients with congenital agammaglobulinemia (Table 3) . We observed enzyme activities of 21.2 (11.9-33.6) nmol/hr per 106 cells in normal subjects and 7.1 (3.3-11.8) nmol/hr per 106 cells in these patients with congenital agammaglobulinemia. These observations suggest that the enzyme deficiency originally Immunology: Edwards et al.
described in mixed peripheral mononuclear cells (2) also involves T cells and is not simply due to the absence of B cells in these patients.
DISCUSSION
The enzyme 5'-nucleotidase is localized to the plasma membrane and catalyzes the dephosphorylation of 5'-nucleotide monophosphates (AMP, IMP, GMP) by a hydrolysis reaction. The large difference in 5'-nucleotidase activity between T and B lymphoblasts (6, 7) hag prompted the measurement of this enzyme activity in human lymphoid tissues. The current observations indicate that normal human thymocytes have a low value for 5'-nucleotidase similar to that seen in T lymphoblasts. Peripheral blood mononUclear cells and tonsillar cells have a value for 5'-nucleotidase similar to B lymphoblasts. Observations by others in human and other mammalian lymphoid tissue support these data (19) (20) (21) (22) (23) (24) .
The difference between 5'-nucleotidase activity in thymocytes and peripheral circulating T lymphocytes suggest that this enzyme may be a marker for post-thymic T lymphocytes. The acquisition of greater plasma membrane 5'-nucleotidase activity may be one of many T-lymphocyte surface modifications occurring during T-cell differentiation (25) . Inhibition of 5'-nucleotidase activity by adenosipea,3-methylene diphdsphonate is specific for 5'-nucleotidase but does not affect nonspecific phosphatase (2, 16) . Our observations indicate that the activity measured in peripheral mononuclear cells, th'mocytes, and B lymphoblasts is specific 5'-nucleotidase. The activity in monocytes, granulocytes, and T lymphoblasts is mainly nonspecific phosphatase.
If the hypothesis relating low 5'-nucleotidase activity and lymphocyte sensitivity to deoxynucleoside toxicity is correct (5, 6) , then the low activity of 5'-nucleotidase in human thymocytes should indicate high susceptibility to deoxynucleoside toxicity. Indeed our observations of nucleoside toxicity in thymocytes support this conclusion (unpublished results). In addition, adenosine deaminase inhibition blocks the maturation of precursor T cells to T lymphocytes, but has no effect on mature T cells or the maturation of precursor B cells to immunoglobulin-producing cells (26, 27) . These observations are compatible with the proposed role of 5'-nucleotidase in lymphocyte sensitivity to deoxynucleosides, because it appears that the immature T cells are the lymphocyte population with low 5'-nucleotidase.
The decreased 5'-nucleotidase activity in peripheral blood mononuclear cells from patients with primary immunoglobulin deficiency (1-4) has been reconsidered in the light of the distribution of 5'-nucleotidase in normal lymphoid tissues. Deficient activity of 5'-nucleotidase in these patients could posssibly result from absent B cells, increased monocytes, or decreased T-lymphocyte 5'-riucleotidase. Both the peripheral T and non-T lymphocytes from patients with congenital agammaglkbulinemia and 5'-nucleotidase deficiency have decreased 5'-nucleotidase activity when compared to normal peripheral lymphocyte subpopulations (Table 3) . Thus, the previously observed enzyme deficiency in congenital agammaglobulinemia cannot be accounted for entirely by a shift of mononuclear cell populations. These findings support the hypothesis that abnormal T lymphocytes may be responsible for the perpetuation of disease in certain patients with primary immunoglobulin deficiency (17, 18) .
